| Diagnosis of hypersensitivity pneumonitis in adults: an official ATS/JRS/ALAT clinical practice guideline G Raghu, M Remy-Jardin, CJ Ryerson, JL Myers, M Kreuter, M Vasakova, ... American journal of respiratory and critical care medicine 202 (3), e36-e69, 2020 | 711 | 2020 |
| Lung microbiota contribute to pulmonary inflammation and disease progression in pulmonary fibrosis DN O’Dwyer, SL Ashley, SJ Gurczynski, M Xia, C Wilke, NR Falkowski, ... American journal of respiratory and critical care medicine 199 (9), 1127-1138, 2019 | 256 | 2019 |
| Diagnosis and treatment of fibrotic hypersensitivity pneumonia. Where we stand and where we need to go ML Salisbury, JL Myers, EA Belloli, EA Kazerooni, FJ Martinez, ... American journal of respiratory and critical care medicine 196 (6), 690-699, 2017 | 250 | 2017 |
| Hypersensitivity pneumonitis: radiologic phenotypes are associated with distinct survival time and pulmonary function trajectory ML Salisbury, T Gu, S Murray, BH Gross, A Chughtai, M Sayyouh, ... Chest 155 (4), 699-711, 2019 | 186 | 2019 |
| Computed tomographic biomarkers in idiopathic pulmonary fibrosis. The future of quantitative analysis X Wu, GH Kim, ML Salisbury, D Barber, BJ Bartholmai, KK Brown, ... American journal of respiratory and critical care medicine 199 (1), 12-21, 2019 | 126 | 2019 |
| Idiopathic pulmonary fibrosis: the association between the adaptive multiple features method and fibrosis outcomes ML Salisbury, DA Lynch, EJR Van Beek, EA Kazerooni, J Guo, M Xia, ... American journal of respiratory and critical care medicine 195 (7), 921-929, 2017 | 126 | 2017 |
| Idiopathic pulmonary fibrosis: gender-age-physiology index stage for predicting future lung function decline ML Salisbury, M Xia, Y Zhou, S Murray, N Tayob, KK Brown, AU Wells, ... Chest 149 (2), 491-498, 2016 | 94 | 2016 |
| Development and progression of radiologic abnormalities in individuals at risk for familial interstitial lung disease ML Salisbury, JC Hewlett, G Ding, CR Markin, K Douglas, W Mason, ... American journal of respiratory and critical care medicine 201 (10), 1230-1239, 2020 | 84 | 2020 |
| Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities P Spagnolo, CJ Ryerson, R Putman, J Oldham, M Salisbury, N Sverzellati, ... The Lancet Respiratory Medicine 9 (9), 1065-1076, 2021 | 81 | 2021 |
| Syndrome of combined pulmonary fibrosis and emphysema: an official ATS/ERS/JRS/ALAT research statement V Cottin, M Selman, Y Inoue, AW Wong, TJ Corte, KR Flaherty, MLK Han, ... American journal of respiratory and critical care medicine 206 (4), e7-e41, 2022 | 78 | 2022 |
| Development and validation of a radiological diagnosis model for hypersensitivity pneumonitis ML Salisbury, BH Gross, A Chughtai, M Sayyouh, EA Kazerooni, ... European Respiratory Journal 52 (2), 2018 | 78 | 2018 |
| Exposure assessment tools for hypersensitivity pneumonitis. An official American Thoracic Society workshop report KA Johannson, H Barnes, AP Bellanger, JC Dalphin, ... Annals of the American Thoracic Society 17 (12), 1501-1509, 2020 | 59 | 2020 |
| Effect of antimicrobial therapy on respiratory hospitalization or death in adults with idiopathic pulmonary fibrosis: the CleanUP-IPF randomized clinical trial FJ Martinez, E Yow, KR Flaherty, LD Snyder, MT Durheim, SR Wisniewski, ... Jama 325 (18), 1841-1851, 2021 | 58 | 2021 |
| Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: a cross sectional analysis in ILD patients undergoing lung tissue sampling ML Salisbury, M Xia, S Murray, BJ Bartholmai, EA Kazerooni, CA Meldrum, ... Respiratory medicine 118, 88-95, 2016 | 58 | 2016 |
| Microbiome in interstitial lung disease: from pathogenesis to treatment target ML Salisbury, MLK Han, RP Dickson, PL Molyneaux Current opinion in pulmonary medicine 23 (5), 404-410, 2017 | 49 | 2017 |
| A systematically derived exposure assessment instrument for chronic hypersensitivity pneumonitis H Barnes, J Morisset, P Molyneaux, G Westall, I Glaspole, HR Collard, ... Chest 157 (6), 1506-1512, 2020 | 42 | 2020 |
| Antifibrotic drug use in patients with idiopathic pulmonary fibrosis. Data from the IPF-PRO Registry ML Salisbury, CS Conoscenti, DA Culver, E Yow, ML Neely, S Bender, ... Annals of the American Thoracic Society 17 (11), 1413-1423, 2020 | 38 | 2020 |
| Frailty and geriatric conditions in older patients with idiopathic pulmonary fibrosis JS Sheth, M Xia, S Murray, CH Martinez, CA Meldrum, EA Belloli, ... Respiratory medicine 148, 6-12, 2019 | 36 | 2019 |
| Possible UIP pattern on high-resolution computed tomography is associated with better survival than definite UIP in IPF patients ML Salisbury, LB Tolle, M Xia, S Murray, N Tayob, AM Nambiar, ... Respiratory medicine 131, 229-235, 2017 | 35 | 2017 |
| Multiplatform single-cell analysis identifies immune cell types enhanced in pulmonary fibrosis APM Serezani, BD Pascoalino, JMR Bazzano, KN Vowell, H Tanjore, ... American Journal of Respiratory Cell and Molecular Biology 67 (1), 50-60, 2022 | 31 | 2022 |
